Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Anh-Tuan GAI is a highly skilled Research Scientist at Google DeepMind, based in Paris. His expertise lies in the field of artificial intelligence, with a strong focus on machine learning, computer vision, and generative models. He is dedicated to advancing the frontiers of AI through innovative research and has contributed significantly to the development of novel algorithms and models. Anh-Tuan is recognized for his work on topics such as image generation, understanding complex visual scenes, and improving the efficiency and capabilities of deep learning systems. He obtained his PhD from INRIA / École Normale Supérieure, further solidifying his strong academic and research background.
Anh-Tuan GAI's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Contributes to cutting-edge AI research and development at one of the world's leading AI labs, focusing on machine learning, computer vision, and generative models.
Authored and co-authored numerous influential research papers published in top-tier international AI conferences and journals (e.g., NeurIPS, CVPR, ICCV), advancing the state-of-the-art in visual understanding and AI model development.
Successfully completed doctoral studies with a focus on machine learning and computer vision from prestigious institutions (INRIA / École Normale Supérieure), laying a strong foundation for his research career.
INRIA - Year 2003
Université Montpellier II - Year 2002
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Adagio Therapeutics was a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential, primarily coronaviruses like SARS-CoV-2. They aimed to provide broadly neutralizing antibodies for both treatment and prevention. In 2023, Adagio Therapeutics was acquired by Invivyd (formerly Adimab), and its operations and assets were integrated into Invivyd.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.